{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:13:07Z","timestamp":1786993987343,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T00:00:00Z","timestamp":1547856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["30-1001"],"award-info":[{"award-number":["30-1001"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grant in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science","award":["26860701"],"award-info":[{"award-number":["26860701"]}]}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.mayocp.2018.11.032","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T07:01:03Z","timestamp":1561964463000},"page":"1210-1220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Use of Nitrates and Risk of Cardiovascular Events in Patients With Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"94","author":[{"given":"Tetsuro","family":"Tsujimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kajio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mayocp.2018.11.032_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2018.11.032_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mayocp.2018.11.032_bib3","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00424-014-1480-8","article-title":"Heart failure with preserved ejection fraction","volume":"466","author":"Gladden","year":"2014","journal-title":"Pflugers Arch"},{"issue":"27","key":"10.1016\/j.mayocp.2018.11.032_bib4","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.mayocp.2018.11.032_bib5","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mayocp.2018.11.032_bib6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.mayocp.2018.11.032_bib7","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1161\/01.CIR.99.20.2652","article-title":"Double-blind, placebo-controlled study to evaluate the effect of organic nitrates in patients with chronic heart failure treated with angiotensin-converting enzyme inhibition","volume":"99","author":"Elkayam","year":"1999","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mayocp.2018.11.032_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0002-9343(80)90468-4","article-title":"Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure","volume":"69","author":"Franciosa","year":"1980","journal-title":"Am J Med"},{"issue":"19","key":"10.1016\/j.mayocp.2018.11.032_bib9","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.mayocp.2018.11.032_bib10","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide mononitrate in heart failure with preserved ejection fraction","volume":"373","author":"Redfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.mayocp.2018.11.032_bib11","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2018.11.032_bib12","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ahj.2011.09.007","article-title":"Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction","volume":"162","author":"Desai","year":"2011","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.mayocp.2018.11.032_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.112.972794","article-title":"Baseline characteristics of patients in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist trial","volume":"6","author":"Shah","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"12","key":"10.1016\/j.mayocp.2018.11.032_bib14","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/2047487318780035","article-title":"Efficacy of renin-angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease","volume":"25","author":"Tsujimoto","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"22","key":"10.1016\/j.mayocp.2018.11.032_bib15","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.jacc.2017.09.1111","article-title":"Abdominal obesity is associated with an increased risk of all-cause mortality in patients with HFpEF","volume":"70","author":"Tsujimoto","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mayocp.2018.11.032_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2018.04.031","article-title":"Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction","volume":"263","author":"Tsujimoto","year":"2018","journal-title":"Int J Cardiol"},{"issue":"9641","key":"10.1016\/j.mayocp.2018.11.032_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"BEAUTIFUL investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocp.2018.11.032_bib18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"issue":"3","key":"10.1016\/j.mayocp.2018.11.032_bib19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.mayocp.2018.11.032_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jama.2012.96867","article-title":"Prespecified falsification end points: can they validate true observational associations?","volume":"309","author":"Prasad","year":"2013","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.mayocp.2018.11.032_bib21","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mayocp.2018.11.032_bib22","doi-asserted-by":"crossref","first-page":"e0179307","DOI":"10.1371\/journal.pone.0179307","article-title":"Is normal-tension glaucoma a risk factor for stroke? A 10-year follow-up study","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mayocp.2018.11.032_bib23","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2307\/2533444","article-title":"Robust variance estimation for the case-cohort design","volume":"50","author":"Barlow","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.mayocp.2018.11.032_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2017.12.109","article-title":"Favorable effects of statins in the treatment of heart failure with preserved ejection fraction in patients without ischemic heart disease","volume":"255","author":"Tsujimoto","year":"2018","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.mayocp.2018.11.032_bib25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.recesp.2011.06.008","article-title":"Propensity score methods for creating covariate balance in observational studies [in Spanish]","volume":"64","author":"Pattanayak","year":"2011","journal-title":"Rev Esp Cardiol"},{"issue":"19","key":"10.1016\/j.mayocp.2018.11.032_bib26","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2014.15241","article-title":"Association between use of \u03b2-blockers and outcomes in patients with heart failure and preserved ejection fraction","volume":"312","author":"Lund","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocp.2018.11.032_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.mayocp.2018.11.032_bib28","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low myocardial protein kinase G activity in heart failure with preserved ejection fraction","volume":"126","author":"van Heerebeek","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mayocp.2018.11.032_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2018.11.032_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCHEARTFAILURE.114.001598","article-title":"Nitrate\u2019s Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction trial: rationale and design","volume":"8","author":"Zakeri","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.mayocp.2018.11.032_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003534","article-title":"Association between use of long-acting nitrates and outcomes in heart failure with preserved ejection fraction","volume":"10","author":"Lim","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"19","key":"10.1016\/j.mayocp.2018.11.032_bib32","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.110.981407","article-title":"Nitrate therapy: new aspects concerning molecular action and tolerance","volume":"123","author":"M\u00fcnzel","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mayocp.2018.11.032_bib33","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jacc.2011.09.062","article-title":"Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy","volume":"59","author":"Schwartzenberg","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2018.11.032_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.vph.2014.09.002","article-title":"Organic nitrates: update on mechanisms underlying vasodilation, tolerance and endothelial dysfunction","volume":"63","author":"M\u00fcnzel","year":"2014","journal-title":"Vascul Pharmacol"},{"issue":"15","key":"10.1016\/j.mayocp.2018.11.032_bib35","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199910073411501","article-title":"Body-mass index and mortality in a prospective cohort of U.S. adults","volume":"341","author":"Calle","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.mayocp.2018.11.032_bib36","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/archinte.164.13.1422","article-title":"The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up","volume":"164","author":"Almdal","year":"2004","journal-title":"Arch Intern Med"},{"issue":"9349","key":"10.1016\/j.mayocp.2018.11.032_bib37","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"issue":"25, pt B","key":"10.1016\/j.mayocp.2018.11.032_bib38","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9438","key":"10.1016\/j.mayocp.2018.11.032_bib39","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocp.2018.11.032_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","article-title":"Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap","volume":"134","author":"Shah","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mayocp.2018.11.032_bib41","doi-asserted-by":"crossref","first-page":"9556","DOI":"10.1038\/s41598-018-27799-y","article-title":"Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction","volume":"8","author":"Tsujimoto","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.mayocp.2018.11.032_bib42","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/CIRCULATIONAHA.117.028002","article-title":"Physical activity and prognosis in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial","volume":"136","author":"Hegde","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mayocp.2018.11.032_bib43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.mayocp.2018.11.032_bib44","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jacc.2015.07.067","article-title":"Sodium nitrite improves exercise hemodynamics and ventricular performance in heart failure with preserved ejection fraction","volume":"66","author":"Borlaug","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.mayocp.2018.11.032_bib45","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/CIRCRESAHA.116.309184","article-title":"Inhaled sodium nitrite improves rest and exercise hemodynamics in heart failure with preserved ejection fraction","volume":"119","author":"Borlaug","year":"2016","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.mayocp.2018.11.032_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003862","article-title":"INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): rationale and design","volume":"10","author":"Reddy","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"17","key":"10.1016\/j.mayocp.2018.11.032_bib47","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.2018.14852","article-title":"Effect of inorganic nitrite vs placebo on exercise capacity among patients with heart failure with preserved ejection fraction: the INDIE-HFpEF randomized clinical trial.","volume":"320","author":"Borlaug","year":"2018","journal-title":"JAMA"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619300461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619300461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T23:46:04Z","timestamp":1569195964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619300461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0025619619300461"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.11.032","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Nitrates and Risk of Cardiovascular Events in Patients With Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}